3 ·Filed Mar 27, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
No material ownership data was disclosed in the filing; monitor for future Form 4 or amended Form 3 filings that may reveal actual shareholdings or transactions by the CEO.
Final — all horizons settled through T+60d
ONCO ▼ -93.76% at T+60d
NEUTRAL call ✗ call lost -93.76% · α vs SPY -110.25% · entry $15.70 → $0.9798
T+1d
-5.10%
call -5.10% · α -7.99%
$14.90
settled 6mo ago
T+5d
-17.83%
call -17.83% · α -22.13%
$12.90
settled 6mo ago
T+20d
-51.07%
call -51.07% · α -63.67%
$7.68
settled 5mo ago
T+60d
-93.76%
call -93.76% · α -110.25%
$0.9798
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
David Allan White, CEO of Onconetix, Inc., filed a Form 3 disclosing his initial beneficial ownership of the company's securities as of March 18, 2026. The filing is a routine regulatory requirement and does not disclose any specific share ownership amounts or transactions.
Key Facts
- Form 3 filed by David Allan White, Chief Executive Officer of Onconetix, Inc.
- Reporting date for ownership: March 18, 2026
- Filing made on March 27, 2026
- No specific number of shares or ownership percentage disclosed in the available documents
- Onconetix, Inc. is a pharmaceutical preparations company formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc.
Financial Impact
No financial impact disclosed — no share amounts or values reported
Risk Factors
- Lack of disclosed ownership details limits insight into insider stake or alignment with shareholders
- Very small market cap ($2M) increases stock volatility risk, especially if future filings reveal concentrated ownership
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-035509 |
| Document: 0001213900-26-035509-index.html | 0001213900-26-035509 |
| Document: 0001213900-26-035509.txt | 0001213900-26-035509 |
22 reports for ONCO
67% Hit rate best @ T+60▲ +78.04%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | DEFA14A / 8-K | $0.6374 $0.6549 | ▲ +2.75% | ▲ +2.64% | $0.7440 (+16.72%) |
Sep 14, 2026 18d ago | 8-K | $0.6374 $0.6549 | ▼ −2.75% | ▼ −2.64% | $0.7440 (−16.72%) |
Sep 14, 2026 18d ago | 425 | $0.6374 $0.6549 | ▼ −2.75% | ▼ −2.64% | $0.7440 (−16.72%) |
Sep 4, 2026 28d ago | EFFECT | $1.02 $0.6374 | ▲ +37.51% | ▲ +36.30% | $0.7440 (+27.06%) |
Sep 3, 2026 29d ago | 425 | $0.7390 $0.7564 | ▲ +2.35% | ▲ +3.50% | $0.7440 (+0.68%) |
Aug 31, 2026 4w ago | S-1/A | $0.6528 $0.8132 | ▼ −24.57% | ▼ −24.49% | $0.7440 (−13.97%) |
Aug 12, 2026 7w ago | S-1 | $0.8920 $0.7110 | ▲ +20.29% | ▲ +19.85% | $0.7440 (+16.59%) |
Jul 29, 2026 9w ago | 8-K | $0.7864 $0.9037 | ▼ −14.92% | ▼ −11.29% | $0.7440 (+5.39%) |
Jul 7, 2026 12w ago | 425 | $1.07 $0.8487 | ▼ −20.68% | ▼ −21.23% | $0.7440 (−30.47%) |
Jun 17, 2026 15w ago | EFFECT | $0.9949 $1.00 | ▼ −0.51% | ▼ −1.55% | $0.7440 (+25.22%) |
Showing 10 of 22
US Market Status
Market Closed — Opens Mon (37h 29m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access